Syngenta receives US EPA approval for new high performance fungicide

BASEL, Switzerland, Sept. 14, 2015 /PRNewswire/ -- Syngenta announced today that it has received US EPA approval for ORONDIS^™ a new high-performance fungicide. First sales are expected in the 2016 season.

ORONDIS offers vegetable and specialty crop growers a step change in controlling diseases such as downy mildew and late blight. Its new mode of action complements and expands Syngenta's market-leading fungicide portfolio and helps address increasing resistance to some products. In extensive trials, ORONDIS has shown unparalleled efficacy at significantly lower rates compared with other fungicides.

Davor Pisk, Chief Operating Officer, said: "ORONDIS is the latest launch from our $3.6 billion crop protection pipeline. It offers growers a highly effective and sustainable tool to combat diseases that can devastate crops and diminish yields."

ORONDIS contains the active ingredient oxathiapiprolin. Syngenta secured a license to develop and market products containing oxathiapiprolin from DuPont in 2013 and has exclusive rights for foliar and soil use on all crops in North America and for foliar use on vegetables, grapes and other specialty crops outside North America.

ORONDIS has a peak sales potential of more than $150 million. Launches in several major markets and across a range of crops are planned.

Syngenta is a leading agriculture company helping to improve global food security by enabling millions of farmers to make better use of available resources. Through world class science and innovative crop solutions, our 28,000 people in over 90 countries are working to transform how crops are grown. We are committed to rescuing land from degradation, enhancing biodiversity and revitalizing rural communities. To learn more visit www.syngenta.com and www.goodgrowthplan.com. Follow us on Twitter^® at www.twitter.com/Syngenta.

Cautionary Statement Regarding Forward-Looking Statements

This document contains forward-looking statements, which can be identified by terminology such as 'expect', 'would', 'will', 'potential', 'plans', 'prospects', 'estimated', 'aiming', 'on track' and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. We refer you to Syngenta's publicly available filings with the U.S. Securities and Exchange Commission for information about these and other risks and uncertainties. Syngenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors. This document does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer, to purchase or subscribe for any ordinary shares in Syngenta AG, or Syngenta ADSs, nor shall it form the basis of, or be relied on in connection with, any contract there for.

SOURCE Syngenta International AG

Related Links

http://www.syngenta.com

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED